Investor mix
4 investors on record; lead investors include Businessfinland, Novartis Venture Fund, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Provider of a small molecule drug discovery platform for cancer
4 investors on record; lead investors include Businessfinland, Novartis Venture Fund, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |